Michal Votruba insider trades

Open-market stock purchases and sales by Michal Votruba, Director at BioXcel Therapeutics, Inc, from SEC Form 4 filings since Aug 20, 2015.

Recent trades

DateStockTradeValue
Jan 9, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—

Companies traded

  • BTAI BioXcel Therapeutics, Inc: other filings, last Jan 9, 2026
  • MYND MYnd Analytics, Inc: other filings, last Oct 8, 2018
  • CNSO MYnd Analytics, Inc: other filings, last Apr 5, 2016

Get free alerts when Michal Votruba files a new trade →